Trial Profile
Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Lanreotide (Primary)
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 10 Mar 2014 New trial record